wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40807968-7FFE2A31-26CD-4A57-A60F-3403DA52E8C7
Q40807968-7FFE2A31-26CD-4A57-A60F-3403DA52E8C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40807968-7FFE2A31-26CD-4A57-A60F-3403DA52E8C7
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
P2860
Q40807968-7FFE2A31-26CD-4A57-A60F-3403DA52E8C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40807968-7FFE2A31-26CD-4A57-A60F-3403DA52E8C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b0cf90581734729544457e3c963edf481e542e5
P2860
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.